000299820 001__ 299820
000299820 005__ 20250411111705.0
000299820 0247_ $$2doi$$a10.1016/j.jsb.2025.108193
000299820 0247_ $$2pmid$$apmid:40086706
000299820 0247_ $$2ISSN$$a1047-8477
000299820 0247_ $$2ISSN$$a1095-8657
000299820 0247_ $$2altmetric$$aaltmetric:175210409
000299820 037__ $$aDKFZ-2025-00557
000299820 041__ $$aEnglish
000299820 082__ $$a540
000299820 1001_ $$aMaier, Philip$$b0
000299820 245__ $$aMRGPRX2 ligandome: Molecular simulations reveal three categories of ligand-receptor interactions.
000299820 260__ $$aSan Diego, Calif.$$bElsevier$$c2025
000299820 3367_ $$2DRIVER$$aarticle
000299820 3367_ $$2DataCite$$aOutput Types/Journal article
000299820 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1744362971_25914
000299820 3367_ $$2BibTeX$$aARTICLE
000299820 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000299820 3367_ $$00$$2EndNote$$aJournal Article
000299820 500__ $$a#LA:D190# / Volume 217, Issue 2, June 2025, 108193 / HI-TRON Mainz
000299820 520__ $$aMas-related G protein-coupled receptor (MRGPR) X2 is a mast cell receptor known to be activated by a wide range of ligands of various size, charge and origin. Our aim is to gain a deeper understanding of the binding processes of the different MRGPRX2 ligands and the ligand-receptor interactions in order to identify crucial structural elements for receptor activation.We used the three-dimensional structure of MRGPRX2 described in Nature in 2021 by Cao et al. and Yang et al. to computationally model the interaction between MRGPRX2 and small molecule ligands under simulated physiological conditions.Docking and post-docking samplings of the MRGPRX2 ligandome within the GPCR binding pocket led to the identification of key structural features for protein-ligand interactions. On the ligand side, we obtained an overlay of different molecular patterns or chemical groups by comparing different ligands plotted on the receptor. These key features include at least one protonated amine moiety of MRGPRX2 ligands contributing to one salt-bridge and one π-cation interaction, as well as an extended non-polar domain of the ligand surface that offer hydrophobic segregation and/or π-stacking interactions. In the receptor, we identified amino acids (GLU164, ASP184, PHE101, PHE170, TRP243, PHE244 and PHE257) that specifically interact via hydrogen bonding, salt-bridges, π-cation interactions and π-π stacking with the ligands to direct binding and ultimately receptor activation.Our insights into ligand-receptor interaction obtained by molecular modeling can help to predict mast cell activation via MRGPRX2 including adverse reactions, and facilitate the development of MRGPRX2 antagonists for the treatment of mast cell-mediated diseases.
000299820 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000299820 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000299820 650_7 $$2Other$$aDocking
000299820 650_7 $$2Other$$aLigand-receptor interaction
000299820 650_7 $$2Other$$aMas-related G protein coupled receptor X2
000299820 650_7 $$2Other$$aMolecular recognition
000299820 650_7 $$2Other$$aPharmacophore
000299820 7001_ $$aMacht, Moritz$$b1
000299820 7001_ $$aBeck, Silvan$$b2
000299820 7001_ $$aKolkhir, Pavel$$b3
000299820 7001_ $$aBabina, Magda$$b4
000299820 7001_ $$aKremer, Andreas E$$b5
000299820 7001_ $$aZahn, Dirk$$b6
000299820 7001_ $$0P:(DE-He78)e107b92b947a96777fe426a2ea115115$$aWolf, Katharina$$b7$$eLast author$$udkfz
000299820 773__ $$0PERI:(DE-600)1469822-5$$a10.1016/j.jsb.2025.108193$$gp. 108193 -$$n2$$p108193 $$tJournal of structural biology$$v217$$x1047-8477$$y2025
000299820 909CO $$ooai:inrepo02.dkfz.de:299820$$pVDB
000299820 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e107b92b947a96777fe426a2ea115115$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000299820 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000299820 9141_ $$y2025
000299820 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2025-01-07$$wger
000299820 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ STRUCT BIOL : 2022$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000299820 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-07
000299820 9202_ $$0I:(DE-He78)D190-20160331$$kD190$$lHI-TRON zentral$$x0
000299820 9201_ $$0I:(DE-He78)D190-20160331$$kD190$$lHI-TRON zentral$$x0
000299820 980__ $$ajournal
000299820 980__ $$aVDB
000299820 980__ $$aI:(DE-He78)D190-20160331
000299820 980__ $$aUNRESTRICTED